Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

AACN Practice Alert outlines evidence-based protocols related to bathing adult patients

The long-held tradition of using a basin, soap and water to bathe bed-bound hospitalized patients is no longer the recommended standard of practice, according to the American Association of Critical-Care Nurses.

19 Apr 2013

Ribavirin, interferon-alpha 2b inhibit virus replication in cell culture, NIH study finds

National Institutes of Health scientists studying an emerging coronavirus have found that a combination of two licensed antiviral drugs, ribavirin and interferon-alpha 2b, can stop the virus from replicating in laboratory-grown cells.

19 Apr 2013

North American scientists chart new territory in immunity research

Cracking the DNA code for a complex region of the human genome has helped 14 North American scientists, including five at Simon Fraser University, chart new territory in immunity research.

19 Apr 2013

Pediatric allergist offers tips to protect kids from allergies during the spring

Spring is having a hard time deciding if it wants to be here this year. Still, for many allergy sufferers its presence is being felt. Allergies are extremely common with an estimated 50 million people in the United States suffering from them.

19 Apr 2013

Patient enrollment underway in Phase III trial program to evaluate amikacin inhalation solution

Bayer HealthCare Pharmaceuticals Inc. announced today that patient enrollment is underway in its global Phase III trial program to evaluate the efficacy and safety of adjunctive aerosolized BAY41-6551 versus aerosolized placebo in the treatment of intubated and mechanically ventilated patients with Gram-negative pneumonia receiving standard of care intravenous antibiotics.

19 Apr 2013

Proposed food aid reform garners mixed reaction from lawmakers, AP reports

"Rajiv Shah, the administrator of [USAID], said Tuesday that the system of shipping U.S.-grown food abroad has been inefficient and that changes are necessary as a humanitarian crisis in Syria and recent droughts in Africa sap food aid from other countries in need," the Associated Press reports.

18 Apr 2013

New assays are effective in managing patients with influenza virus infection

Over 40,000 people die each year in the United States from influenza-related diseases. In patients whose immune systems are compromised, antiviral therapy may be life-saving, but it needs to be initiated quickly. It is therefore crucial to diagnose and type the influenza rapidly.

18 Apr 2013

New combination therapies with anti-sickling capabilities needed for sickle cell disease

Pain is an undeniable focal point for patients with sickle cell disease but it's not the best focus for drug development, says one of the dying breed of physicians specializing in the condition.

18 Apr 2013

Reducing preventable hospital readmissions may take longer, say researchers

Achieving widespread reductions in preventable hospital readmissions among Medicare beneficiaries may take longer than many health care professionals originally anticipated, according to researchers at Penn State, the Weill Cornell Medical College and the University of Pennsylvania.

18 Apr 2013

Health officials have reason to 'remain hypervigilant' over H7N9

"Just as the world was breathing easier about a deadly bird flu virus that killed 371 people over the past decade before dropping out of sight, a different form of bird flu has emerged in China that is causing concern among health experts," a New York Times editorial writes.

18 Apr 2013

H7N9 virus continues to spread; International research team traveling to China to assist

"Two more people in China have died from a new strain of avian influenza, bringing to 16 the number of deaths from the H7N9 virus, and the government has warned that the number of infections could rise," Reuters reports.

18 Apr 2013

GAPPD presents opportunity to meld global, local agendas

"Beyond integration across the two diseases, the [Global Action Plan for the Prevention and Control of Pneumonia and Diarrhea (GAPPD) released by the WHO and UNICEF last week] is an opportunity to meld global and local agendas, giving national governments a comprehensive tool to determine the specific plans, investments, and partners needed to address the unique needs of their countries and achieve the greatest health impact for their citizens," PATH CEO Steve Davis writes in the Huffington Post's "Global Motherhood" blog.

18 Apr 2013

FDA's PADAC supports approval of BREO ELLIPTA as once-daily inhaled treatment for COPD

GlaxoSmithKline plc and Theravance, Inc. today announced that the Pulmonary-Allergy Drugs Advisory Committee to the US Food and Drug Administration voted that the efficacy and safety data provide substantial evidence to support approval of BREO ELLIPTA as a once-daily inhaled treatment for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (9 for, 4 against) and also for the reduction of COPD exacerbations in patients with a history of exacerbations (9 for, 4 against).

18 Apr 2013

Findings hold promise for development of therapies to fight different viral infections

The human body has the ability to ward off viruses by activating a naturally occurring protein at the cellular level, setting off a chain reaction that disrupts the levels of cholesterol required in cell membranes to enable viruses to enter cells.

18 Apr 2013

IDRI, Medicago announce positive Phase I clinical trial results for avian flu pandemic vaccine

IDRI, a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today reported positive interim results from a Phase I clinical trial for an H5N1 Avian Influenza VLP vaccine candidate.

18 Apr 2013

Study: Half of Tamiflu prescriptions during 2009-10 influenza pandemic went unused in England

A new study concludes that approximately half of the prescriptions of Tamiflu during the 2009-10 influenza pandemic went unused in England.

18 Apr 2013

Flunisyn Phase 2a trial data shows positive results in elderly population

Following the widely publicised US Centers for Disease Control and Prevention report in February that the current season's flu vaccine is only 9% effective in the over-65 population, Immune Targeting Systems Limited, today announces positive data from a Phase 2a trial with the Company's lead pan-strain influenza A T-cell vaccine, Flunisyn, in the elderly population.

17 Apr 2013

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

AACN Practice Alert outlines evidence-based protocols related to bathing adult patients

Ribavirin, interferon-alpha 2b inhibit virus replication in cell culture, NIH study finds

North American scientists chart new territory in immunity research

Pediatric allergist offers tips to protect kids from allergies during the spring

Patient enrollment underway in Phase III trial program to evaluate amikacin inhalation solution

Proposed food aid reform garners mixed reaction from lawmakers, AP reports

New assays are effective in managing patients with influenza virus infection

New combination therapies with anti-sickling capabilities needed for sickle cell disease

Reducing preventable hospital readmissions may take longer, say researchers

Health officials have reason to 'remain hypervigilant' over H7N9

H7N9 virus continues to spread; International research team traveling to China to assist

GAPPD presents opportunity to meld global, local agendas

FDA's PADAC supports approval of BREO ELLIPTA as once-daily inhaled treatment for COPD

Findings hold promise for development of therapies to fight different viral infections

IDRI, Medicago announce positive Phase I clinical trial results for avian flu pandemic vaccine

Study: Half of Tamiflu prescriptions during 2009-10 influenza pandemic went unused in England

Flunisyn Phase 2a trial data shows positive results in elderly population

Albert Einstein College of Medicine joins New York Genome Center

Study exposes unexpected features of why humans sometimes make incorrect decisions

Study finds no evidence that digoxin increases mortality in patients with atrial fibrillation

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in